Philip Morris
Smoking Cessation and Mortality Trends Among Two United States Populations
Fields
- Author
- Enstrom, J.E.
- Document File
- 2505585888/2505586502/D. Lee 1053 -
- Area
- BADSTUBER,ANDRE/OFFICE
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- ABST, ABSTRACT
- Litigation
- Feda/Produced
- Site
- E16
- Master ID
- 2505586205/6235
Related Documents:- 2505586205 Untitled Document 2505586205
- 2505586206-6212 Review 1098 "Smoking Cessation and Mortality Trends Among Two United States Populations" J E Enstrom Journal of Clinical Epidemiology (990000), 52, 813-825
- 2505586226-6228 Review 1099 "An Examination of Cigarette Brand Switching to Reduce Health Risks" C K Haddock Et Al Annals of Behavioural Medicine (990000), 21, 128-134
- 2505586229-6235 An Examination of Cigarette Brand Switching to Reduce Health Risks
- Named Organization
- Ctr, Council for Tobacco Research
- Natl Center for Health Statistics
- NCI, Natl Cancer Inst
- Natl Center for Health Statistics
- Author (Organization)
- Elsevier Science
- J Clin Epidemiol
- Jonsson Comprehensive Cancer Center
- Univ of Ca Los Angeles
- J Clin Epidemiol
- Date Loaded
- 11 Sep 2002
- UCSF Legacy ID
- wve19c00
Document Images
jmoking Cessatinn and \L,rcaliry Trtnds
823
APPENDIX TABLE 5. Relative risk of death (RR and 95% CI) by length of time quit as of entry date
(195411957) for al1 former
cigarette smokers (n = 43,559) compared with those who never smoked regularly (n = 59,351) among
U.S. veteran males of
all ages for selected causes of death
Cause of death
All former smokers
All causes
Allcancer
BC, esu, or ca
Lung cancer
Other cancer
AIlCVD
Coronary HD
Stroke
Bron, emp, asthma
<5
n=15,196
1.61 (1.52-1.71) 159311
1-76 (1-54-2.25) [1100/
3.47 (1.84-6.56) [401
10.16 (7.19-14.36) [1521
1.15 (0.97-L36) [9081
157(L46-L.69)[38931
1.56 (1-42-1.70) [26641
1.36 (1.07-1.73) [440)
14.67 (8.87-24.27) [82]
RR by length of time quit in years
5-9
n = 9,348
138 (1.25-1.45) 153771
1.62 (1.38-1.89) [10001
2.08 (0Q89-4.5(,) [301
6.36 (4.27-9.47) [971
1.28(L06-133)[8731
L35 (1.24-L48) [35571
1.35 (1.2t-I50) [24251
1.15 (0.87-L51 ) (4121
7.55 (4.25-13.43) (471
10-14
n = 5,735
L33(L?2-1.45)[50471
1.42 (1.16-1.73) [9191
0.45 (0.06-3.31) [24]
3.28 (L86-5.75) [66]
1.32 (L07-L64) [8291
1.31 (1.I8-L46) [3348(
1.39 (1.23-1.58) [2296]
1.19 (0.87-L.64) [396)
3.49 (1.56-7.30) (311
?15+
n = 13,280
1.05 (J.99-1.12) [56361
1.20 (1.D4-1.39 ) [10471
1.33 (0.59-2.99) [3l1
1.77 (1,01-2.92) [72]
1.16 (1.00-I.35) (9441
L01 (0.93-1.10) (37I8[
0.99 (0.90-L09) (2516
0.99 (0.73-1.24) (445/
235 (1,2 1-i.58) 1371
APPENDIX TABLE 6. Relative risk of death (RR and 95% Cl) by decade among all 19i4-1957 current
cigarette smokers
(n = 97,518) compared with those who never smoked regularly (n = 59,351) among U.S- veteran males of
all ages for selected
cause of death
Cause of death
All cau5ls
All cancer
BC, csu, ur ca
Lung cancer
Other cancer
All CVD
Coronary HD
Stroke
Bron, emp, asthma
1954-1959
L63 (1.57-1.69) [14,2311
1.97 (l-8'1-2.14) [29431
4.92 (3.17-7.65) [171]
10.29 (7.72-13.71) [7361
1.32 (1.20-1.44) [20361
1.55 (1.49-1.62) [90951
1.55 (1.47-1.63) [62501
L27 (1.12-L46) [9321
6.24 (4.04-9.63) [2051
RR by decade of follow-up
1960-1969
1.69 (1.65-1.72) [41,2541
2.11 (2.01-2.22) [79731
6.10 (4.48-830) [4001
10.95 (9.24-12.98) (21471
1.38 (1.30-L.46) [34311
1.51 (1.47-1.55) [?4,8771
1.51 (1.46-1.56) [59181
1_29 (L21-L38) [3i71(
10.11 (8.24-12.40) [13131
1970-1979
13'_ ( L49-1.95) [45,086]
L90 ( L82-2_00) [8206]
4.C0 (3.09-5i.19) [3881
1 ~`.85 (9.17-12.84) L19461
1-30 (1 24-1.37) [58721
1.33 (1.30-137) [26,0591
L31 (1.27-136) (15,2381
L.?0 ( L L3-1.27) [5266
11 72 (930-14-78) [9981
1954-1979
1.60 (1.53-L62) [100,571)
2.00 (1.94-2.06) [19,12 i1
4.88 (4.07-i.84 ) (9591
10.86 (9.73-12.13) ['48291
1.34 (l.'_9-1.38) [13,3391
1.43 (1.41-1.46) [60,0311
1.43 (1 .4tL1.46) [37,4061
1.24 (1.19-1.29) [99691
10.28 (8.9C-11.88) 125161
APPENDIX TABLE i. Relative risk of death (RR and 95% CI) by decade among all 1954/57 current
cigarette smokers by num-
ber ber of cigarette per day compared with those who never smoked regularly among U.S. veteran males
of all ages for all causes
_ and lung cancer. Adjusted total is a weighted average based on the smoking distribution as of
195-V/57
Cause of death
AIl causes
Adjusced total
<l cYg/dav
(n = 4,115)
1-9 cigs/day
(n = 13.147)
10-20 cigslday
(n = 45,492)
21-39 cigs/day
(n=28,932)
?40 cigs/day
(n = 4.932)
Lungcancer
Adjusted total
<I cig/day
1-9 cigs/day
10-20 cigs/day
21-39 cigs/day
y40 cigs/day
I954-1959
1 63 (1.57-1.69)
L14 (1:02-1.28) 147911
1 23 (L16-L.31) [i6741
1.61 (1.54-L68) [9C461
1.92 ( 1 .34-2.0. ) 175091
2.19 ('-.01-2.33) [50951
10.3 (7.7-13.7)
3.53 (1.84-6.77) [611
4.39 (2.96-6.53) [981
8.28 (6.11-11.21) [3111
16.85 (12_44-2282) [338J
25.10 ( 17.47-36.07) (128]
RR by decade of follow-up
1960-1969
1]0(I_66-L73)
1.16 (1-09-1 2 4) [14_'631
L.30 (L25-L35) [I "0.9141
1.66 (L.62-1.7i) 176,3341
2D 1 (1.96-2.07 ) 121,8831
2.39 ( 2.28-2.91) (15.0791
1970-1979
1.55 (1.5 2-1.56 )
I.I'_ ( L06-1-19) [19.3041
1.19 (L15-1.23) [3l.>491
1.51 (1-45-1.55) 130.5561
I 36 ( I.31-I .91) 1=5.6611
2_03 ( L.92-2.15) 118,9921
10.9 (9.2-12.9)
3.60 (2.47-5.26) (1761
3.77 (Z.95-4.83) [256]
10.03 (8.40-11-98) [1009I
16.82 (14.05-20.14) [9391
23.47 (18.83-29.25) [339(
11,1 (9.5-13.7,)
3.44 (2.34-5.05)[1801
4.12 (3.23-5.26) [2631
10.26 (8.59-12.24) [9411
17-50 (14.61-20.96) [8671
21.03 (16.56-26.71) (287j
195J-1979
L62(L6:-1.64)
1_14 ( 1_29-1-19) [37,s631
1 24 0 -'_1-L1-7) 144,1371
158 (1.56-L.6U [65,9361
1.93 (1 ~C-1.97) (55,0531
2.21 (2.14-'_'9) (39,1661
1 1.0 (9.E-1=.2 )
3.54 ('-76-4.55) [4171
4.02 ( 3.43-4.71) [6171
R92 (8-94-1 L.14) (22611
17.19 (15.'_3-19.33) [21441
22.75 (19.63-26.37) 1754[

814
smokers the longer the former smokers have noc smoked
[4[. Among former smokers, whose smoking atatus was de-
termined at the time they entered an epidemiological study,
the decline in risk of death compared with never-smokers
begins during the first 5 years after quitting and continues
for at least 10-15 years. After 15 years, the risk of all-cause
mortality returns nearly to that of never-smokers and the
risk of lung cancer mortality drops to about twice that of
never-smokers.
The observational studies have the limitation that the
reported benefits of cessation are based on mortality pao-
terns among persons who were already former smokers at
the time they enrolled and were classified by the number of
years since they last smoked at time of enrollment. The self-
selected former smokers who enrolled in these studies are
those who were alive at rhe time the study began. A former
smoker who stopped 15 years before the study began is by
definition one who remained alive those 15 years. Former
smokers who died before the study began would obviously
not be included and might be different than the self-selected
former smokers who were included.
The mosc rigorous tvay to evaluate cessation is to ran-
domly assign smokers to either a cessation intervention or
no intervencion in a randomized controlled trial (RGT).
There has been just one completed RCT designed to evalu-
ate smoking cessation alone: the Whitehall Civil Servants
Study of 1445 middle-aged whire men in London [5J. There
has been one RCT in which smoking cessation was the ma-
jor risk factor change during 6 years of intervention: the
Multiple Risk Factor Incercention Trial (MRFIT) of 12,866
middle-aged white men in the United States (61. Initially,
both studies showed substantially more smoking cessation
in the intervention group relative to the control group
(about 45% versus 20% in MRFIT averaged over 6 years
and about 60% versus 254o in Whitehall averaged over 9
years), but the cessation differences diminished substan-
tially over time. For the intervention groups relative to
their respective control groups, the total mortality during
16-20 years of follott-up was 6% less in the MRFIT and 7%
less in Whitehall; lung cancer mortality was 15 :b more in
MRFIT and 10% less in Whitehall. None of these differ-
ences are statistically significant. The ongoing Lung Health
Study, designed to evaluate smoking cessation among 3, 702
men and 2.185 women, shotts no differences in lung cancer
or total mortalicy durin_ the first 5 years 171. So the RCTs
have not definitivek confirmed the value ofsmokrng cessa
cion, but they are limited by the fact chat they were not able
to sustain a large difference in smoking cessation between
intervention and conaol groups-
We provide additional insight into this issue b% evaluat-
ing natural experiments of smoking cessation among two
U.S. cohorts, whereby the smokers as a whole largely quit,
and consequently their smoking-related death races should
converge toward the corresponding death rates among
those who have never smoked. A natural experiment ap-
J. E. Ensmtnt
prosintates a concrolled experimenc, and inferences abouc
etiological factots derived from such situations are consid-
erably stronger than inferences derived solely front an ob-
servational study, but they are not as strong as those drawn
from an RCT [8[. The study of 6ritish physicians is a prime
example of a natural experiment (9J. The British study in-
volved 34,440 physicians who substantially reduced their
cigarette smoking from 1951 to 1971 and whose lung can-
cer death race declined relative to the general population
rate and converged toward that of nonsmokers during these
20 years. The major mortality benefits of cessation were
among smoking-related causes in physicians less than age
6) at death, with no overall benefits for ages 65 and older (9[.
1954-79 U.S. VETERANS STUDY
METHODS
This is a studv of U.S. veterans who held Go.'ernment Life
Insurance Policies, primarily white men tcho served in
World War 1(WW I) [10-131. A questionnaire requesting
informatinn about the use of tobacco, residence, usual oc-
cupation. and industrv of employment was mailed to about
295.t'Ct' eligible subjects in January 1954. After a second
mailin~ in January [957, a total of 248,046 (8-f°.6) policy
holders, ased 30-84 years, responded There were _'C0,428
veterans who ever or never smoked cigarettes regularly. Of
thesr, 136.302 (68%) were born during 1890-1899, essen-
tially all of tt'hom were W W I veterans.
They tcere followed up for survival from Januarq L. 19~-{
through September 30, 1980, using Veterans Administra-
tion (VA) records, as described elsewhere (10-13]. Causes
of death wue obtained from VA claims folders or front stare
tital records. The underlying cause of death was coded from
the death certificates for 97% of all deaths by trained nosol-
ogisrs actordin, to the International Classification of Dis-
eases, Se, enrh Revision (ICD7). These veteran cohort dara
are on a publically available data file maintained by the Na-
tional Cancer Institute [13[.
Current cigaretce smokers have been defined as all te[er-
ans currenrk smokim, ci,,arettes at time of enrollnxnt in
1954 or 195 i, re, udless of whether they also smoked cigars
andior piprs. Veterans rcho never smoked regul;trly are
chose it tuuc of enrollment, had never smoked ciaa-
rettet, ciQac. or pipes or h:rd smoked them onk occa>ion-
alk. Former cigarette smokers include all cigarette smokers
ttho had quic smoknt, dgarectes at time of enrollmenc, re-
gardles> of their cwar artd/or pipe smoking history. These
definicions are consi.stent with rhose used in most pre, ious
analvses [1'-I_'I but are slightly different than those used
recentlq (131
-
We have amalyced the U.S. Veterans cohort using Cox
proporriunal h;cnrds regression to determine the relative
risk (RR) of death and 95% confidence interval (CI) over
time for persons who smoked cigarettes at enrollment com-
F_
I

f
5moking Cessation and Mortality Trends
The author thanks the National Cancer I nstittrte and the Narional Crn-
ter for Health Statistics for making available to me the data files ttpon
which this research is based. This research has been supported in part by
a grant from The Courutl for Tobaaro Research - U.S.A:. Inc.
References
1. McGinnis JM, Foege WH. Actual causes of death in the .
United Srates. JAMA 1993; 270: 2207-2212.
2. Centers for Disease Control. Surveillance for selected to-
bacco-use behaviors-United Sratea. MMWR 1994; 43: 1-43.
3. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statis-
tics, 1999. CA Cancer] Clin 1999; 49: 8-31.
4. The Health Benefits of Smoking Cessarion-A Report of rhe
Surgeon General, Rockville, MD: Public Health Service;
1990. DHHS Publication No. (CDC) 90-8416.
5. Rose GA, Colwell L. Randomized controlled aial of anti-
smoking advice: Final (20 year) results. J Epidemiol Commu-
nity Health 1992; 46: 75-77.
6- The MRFIT Research Group. Morralicy afrer 16 rears for par-
ticipants randomized to the Multiple Risk Factor Intervention
Trial (MRFIT). Circulation [996; 94:946-951.
7. Anthonisen NR, Connett JE, Kiley JP, Ahose MD, Bailey
WC. Buist AS, et aI. Effects of smoking intervention and the
use of an inhaled anticholinergic bronchodilator on the Tate
of decline of FEV 1(The Lung Health Study). JAMA 1994;
272:1497-1505.
8. Lilienfeld AM, Lilienfeld DE. Foundations of Epidemiology.
New York:Osford University Press, 19SQ pp. 10-1 l.
9. Doll R, Peto R. Mortality in relation to smoking: '_0 years' obser-
vations on male British doctors. Br Med ] 1976; 2- 1525-1536.
10. Kahn HA. The Dom study of smoking and mortality among
U.S. veterans: Report on eight and one-half qears of observa-
tion. Nad Cancer Inst Monogr 1966; 19: 1-125.
l1. Rogot E, Murray JL. Smoking and causes of death among U.S.
Veterans: 16 years of observacion. Public Health Rep 1980;
95: Z13-2??.
12.. Rogot E, Hrubec Z. Trends in mortnlipfrom curonan• heart
disease and stroke amone U.S. Veterans: 1954-79. J CIEn Epi-
demiol 1989; 42: 24i-256.
3. McLaughlin JK, Hrubec Z. Biot WJ, Fraumeni JF Jr. Smoking
L"and cancer mortality among U.S. veterans: a'_6-,ear follorc-
up.IntJ Cancer 1995; 60: 190-193. -
825
l4. Harrell F. The PHREG procedures. In: SUGI Supplemental
Library Uscr's Guide, 1989 Edition. Carn. NC: SAS lnsti-
tute; 1989. 15. Haens;el W, Shimkin MB, Miller HP. Tobacco smoking pat-
terns in the United States. Washington. DC: U.S. Govem-
ment Printing Office; 1956, Public Health Monograph No. 45.
l6. Erucrom JE, Godlev FH. Cancer mortality among a represen-
tatice sample of nonsmokers in the United States during
1966-68. J Natl Cancer Inst 1980; 65: l 175-1183.
17. U.S. Bureau of the Census. Current Population Survey, Sep-
cember 1985. Washington, DC.
l8. Giocino GA, Schooley MW, Zhu BP, Chrisman JH, Tomar
SL, Peddicord JP, et al. Surveillance for selected tobacco-use
bchariors-United State>, 1900-1994. MMYVR 1994: 43/Nu.
SS-3: 1-f3.
19. Shopland DR. Tobacco use and its contribution to earlv can-
cer mortality with a special emphasis on cigarette smoking.
Environ Health Perspect 1995; 103 (Suppl 8): 131-142.
20. Bums DIM, Lee L, Shen LZ. Gilpin E, Tullec HD, Vaughn J, et
a!. Cigarette smoking in the United Stares. In: Smoking and
Tobacco Control .Lfonograph 8. Changes in Cigarette-Relared
Disease Risks and Their Implication for Prevention and
Control. National Cancer Institure; 1997: 13-11'. NIH Publ
Na- 97-4213. Bethesda. MD.
21. Enstrom JE Kanim LE, Klein MA. Vitamin C intake and
morralitp among a sample of the United States population.
Epidemiology 1992; 3: 194-20?.
22. Natiunal Center for Health Statistics. Plan and Operation ot
the NHANES I Epidemiologic Followup Study, 1982-84.
Hvattsille, MD= Vital and Health Sratistics; 1987. Series 1.
Number 22. DHHS Publication No. (PHS) S7-1324.
'3. Nationat Center for Health Smtistics. Public Use Data Tape
Documentation. NHANES I Epidemiologic Followup Study.
1992: Viral and Tracing Status. Hyatrsville, V1D: NCHS; 1996.
24. Enstrom JE, Heath CW Jr. Smoking cessation and mortality
trends among 118,000 Californians, 1960-97. Epidemiology
1999;10:999.
25. National Center for Health Statistics. 1986 National Mortal-
in' Folluoback Sunev. Viral and Health Statistics Series 1,
No. 29. DHHS Pub. No. (PHS) 93-1305. Public Health Ser-
cice. Hqact>ville. MD. May 1993 and unpublished tables.
26. Thun YIJ, Day-Lallp CA, Calle EE, Flanders lL'D, Heath CW,
Jr. Excess morrnlity among cigarette smokers, Changes in a
20-ce:v intercal. Am J Public Health 1993; 85: 1223-1230.
